- Home
- TKNO vs NVCT Comparison
TKNO vs NVCT Comparison
Compare TKNO & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TKNO | NVCT |
|---|---|---|
| Founded | 1996 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.1M | 193.4M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | TKNO | NVCT |
|---|---|---|
| Price | $4.01 | $8.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $15.33 |
| AVG Volume (30 Days) | ★ 189.7K | 91.8K |
| Earning Date | 11-06-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $39,801,000.00 | N/A |
| Revenue This Year | $8.79 | N/A |
| Revenue Next Year | $10.52 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.50 | N/A |
| 52 Week Low | $3.60 | $5.34 |
| 52 Week High | $10.37 | $11.52 |
Technical Indicators
Market Signals| Indicator | TKNO | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 39.51 | 68.59 |
| Support Level | $3.75 | $8.00 |
| Resistance Level | $4.86 | $7.91 |
| Average True Range (ATR) | 0.30 | 0.51 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 31.23 | 72.07 |
Price Performance
Historical ComparisonAbout TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.